Tysabri patients

Common Questions and Answers about Tysabri patients

tysabri

Avatar n tn I had been on Tysabri for 22 month's and just recently stopped. I was wondering if any new info. is out there on the drug Rituxan for MS? I have SPMS with RRMS. I was in a study 3 yrs. ago at UCSF and did really well on Rituxan. However, Rituxan is not an approved drug for MS and at that time my insurance would not cover it so I had to discontinue taking it. Or should I just take a break for awhile and not take any ms med"s?
Avatar m tn The thought at the time was that if patients took Tysabri alone, PML would not be an issue. Tysabri was re-released to the market, but with strict conditions and monitoring requirements, known as the TOUCH program. Unfortunately, that has not proven to be true. There have since been cases of PML as well as some deaths in patients who were taking only Tysabri at the time. When I started Tysabri in 2008, the estimated risk of PML was 1 in 1000.
1486292 tn?1291066898 Does anyone have information on Tysabri? I haven't been told much on it, although I have been told by 3 different doctors I should take a look at it. I would like to know what others on it experience or experienced while on it?
Avatar m tn 1) exposure to JC virus 2 time on drug (longer than 2 years) 3) prior exposure to immunosuppression As of 10/2012 there have been a total of ~305 cased of PML to date and about ~108,300 patients exposed to Tysabri to date. Only 54 cases occurred during the 1st twelve infusions. Roughly 21% of the cases were fatal. Only ~20% were able to return to work after treatment. The current PML estimated risk stratification is as follows: Patient with JCV antibody NEGATIVE status: _<0.
4848471 tn?1372238752 htm) The risks and benefits of continuing treatment with Tysabri should be carefully considered in patients who are found to be anti-JCV antibody positive and have one or more of the other known risk factors for PML. Patients with all three known risk factors have an estimated risk of PML of 11/1,000 users. The risk factors are: The presence of anti-JCV antibodies. Longer duration of Tysabri treatment, especially beyond 2 years. Prior treatment with an immunosuppressant medication (e.g.
572651 tn?1530999357 Log on to hear a physician discuss treatment information and to hear a panel of TYSABRI patients share their personal experiences. Ask them questions directly, or just listen to the discussion - all in the comfort of your own home. Registration is easy - at no cost to you. Sign up for free to learn more! Simply call 1 8 66 644 8540 ten minutes before the start of each teleconference.
Avatar f tn Found out yesterday that I have to take 50,000 units of vitamin d to bring that number up. And I'm starting Tysabri. Really don't know what to expect. I would appreciate, anyone who has been on Tysabri, let me know what to expect while on it????
572651 tn?1530999357 The screening test for the JC Virus for patients considering Tysabri as their tretment was officially approved by the FDA today. The test tells if the person has been exposed to the JC Virus or not. PML on tysabri has only occured in people who are JC positive. There has not been a single case of PML in JC negative people. You can read the release here- http://www.medpagetoday.
1168718 tn?1464983535 All i can surmise is possibly patients and doctors are not choosing Tysabri when they their is a high risk factor..... "For JCV antibody–positive patients with no prior immunosuppressant use, the risk for PML increased with longer natalizumab use. For 1 to 24 months of exposure to the drug, the risk was 0.6/1000. With 25 to 48 months of exposure, the risk increased to 5.2/1000, and with 49 to 72 months of natalizumab, the risk was 5.4/1000.
Avatar n tn //www.hpra.ie/docs/default-source/3rd-party-documents/tysabri-physician-information-and-management-guidelines-(version-15-27th-april-2016).pdf?sfvrsn=2 I'm sorry but i too couldn't find anything that specifically links Tysabri and sexually transmitted disease, hopefully the guidelines information will help answer your question. Hope that helps.....
2047903 tn?1330187549 m still OK Tysabri wise speaking. My neuro likes to reevaluate Tysabri use at 24 months. I had infusion # 18 last week. He thinks I would be an excellent candidate for Tecfidera. He said that if DMD'd were ranked from 1-100, in terms of 'power' Tysabri would be 100 and Tecfidera would be 75/80. As my MS seems to be pretty well under control. I may have needed Tysabri to get it under control. but Tecfidera should be able to keep it under control.
Avatar f tn They found out the reason people contracted PML was because they were taking Avonex/and the other MS medications with Tysabri. I think the Tysabri has given me a second chance at helping slow my disease progress, but with out it I would be on no MS medications to slow the disease. I did alot of research before I decided to start the medication and the one resource that helped me make my decision was reading the Tysabri diaries on line. www.msrc.co.uk/index.cfm?
1831849 tn?1383228392 This was another big Tysabri news story at ECTRIMS - researchers in Germany presented results on a blood test that identifies patients who will be safe on Tysabri, even if they are JC positive. http://bit.
Avatar f tn I have had MD for 18 years. Been on Avonex, Betaseron, Tysabri, and now Tecfidera. Unfortunately, I'm also on lots of other medications, mostly due to terrible central pain. My neurologist made me stop the Tysabri after 24 infusions because of safety concerns. I felt my overall best while on Tysabri and have asked him if and when I might be able to go back on the monthly infusions. He does not have an answer for me at this point.
1831849 tn?1383228392 Something new from the man who developed Tysabri. This talks about repairing/reducing inflammation. http://www.businessweek.
147426 tn?1317265632 The Risk of PML is greatest in the setting of a positive J-lymphocytesC virus, greater than 24 months of Tysabri, and concurrent use of other DMD's or steroids. Those are old recommendations, and new info will change them in the (near?) future. PML is caused by the J-C Virus. A little more than half of all people have been infected with the JC virus. It generally lives asymptomatically in the brain unless something has occurred to cause the immunity of the brain to be compromised.
1637739 tn?1371688706 He asked me whether I was interested in being in the Tysabri study. I am only 37 and have only had one relapse. I know I will be deciding on a treatment and not sure what direction to go. This neuro is big in research and he spent a lot of time talking with me about MS. He mentioned a JC Virus and took my blood to look for it. If I don't, I would be a good candidate for Tysabri. It has 67% reduction in relapses but also risks getting PML.
1115136 tn?1258778476 Hi Ellador, I just completed my 41st Tysabri infusion the day before Thanksgiving. For me, since restarting the medication in October 2006, I have not had one single relapse nor any new lesions on my recent MRIs.
Avatar f tn Will Tysabri help me if I can't walk very good at all? It's everyday all day,I think I have progressed from RRMS to Secondary progressive.
488198 tn?1493875092 Studies have just been released noting that psoriasis patients in Europe have come down with PML after using the drug Fumaderm. A key ingredient is the dimethyl fumarate also used in Tecifidera. The media are jumping all over this, and Biogen stock was affected adversely. However, other ingredients are not the same. The FDA was aware of the Fumaderm issues when it approved Tecfidera.
294425 tn?1288528395 And you are right - a big part of the FDA letting Tysabri back on the market in the first place was that Tysabri patients lobbied hard to have it back. Plus, at that time, the thinking was that PML was linked to Tysabri being used in conjunction with other MS treatments, especially interferon. And for 2 years, that seemed to be the case, and everyone was just starting to breathe a sigh of relief... :) Novantrone scares me more, too.